Robert Frist Jr Sells 144,068 Shares of HealthStream (NASDAQ:HSTM) Stock

HealthStream, Inc. (NASDAQ:HSTM) CEO Robert Frist, Jr. sold 144,068 shares of the firm’s stock in a transaction on Monday, September 14th. The stock was sold at an average price of $29.50, for a total transaction of $4,250,006.00. Following the transaction, the chief executive officer directly owned 3,907,038 shares of the company’s stock, valued at approximately $115,257,621. This represents a 3.56% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

HealthStream Stock Up 0.1%

Shares of HSTM traded up $0.02 during midday trading on Tuesday, hitting $29.65. The company had a trading volume of 202,612 shares, compared to its average volume of 262,836. The stock has a market cap of $866.22 million, a price-to-earnings ratio of 41.18, a PEG ratio of 3.37 and a beta of 0.44. The company’s 50 day moving average price is $28.61 and its 200 day moving average price is $25.02. HealthStream, Inc. has a 52 week low of $19.50 and a 52 week high of $31.11.

HealthStream (NASDAQ:HSTM) last posted its quarterly earnings results on Monday, August 3rd. The technology company reported $0.23 EPS for the quarter, topping analysts’ consensus estimates of $0.17 by $0.06. The business had revenue of $83.73 million during the quarter, compared to the consensus estimate of $80.82 million. HealthStream had a return on equity of 6.81% and a net margin of 6.60%. Equities analysts anticipate that HealthStream, Inc. will post 0.72 EPS for the current fiscal year.

HealthStream Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 28th. Stockholders of record on Monday, August 17th were given a $0.035 dividend. The ex-dividend date was Monday, August 17th. This represents a $0.14 annualized dividend and a dividend yield of 0.5%. HealthStream’s dividend payout ratio (DPR) is presently 19.44%.

Analyst Ratings Changes

Several research firms recently issued reports on HSTM. Canaccord Genuity Group upped their price target on HealthStream from $24.00 to $27.00 and gave the company a “hold” rating in a research report on Tuesday, July 21st. Wall Street Zen raised shares of HealthStream from a “hold” rating to a “buy” rating in a report on Sunday, August 30th. Finally, Weiss Ratings upgraded shares of HealthStream from a “hold (c)” rating to a “hold (c+)” rating in a research note on Friday, August 28th. Three investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat, HealthStream has an average rating of “Hold” and an average target price of $27.00.

Hedge Funds Weigh In On HealthStream

A number of large investors have recently bought and sold shares of the business. Essential Partners LLC bought a new position in shares of HealthStream during the first quarter valued at approximately $25,000. Integrated Wealth Concepts LLC bought a new stake in shares of HealthStream in the 2nd quarter worth approximately $27,000. MassMutual Private Wealth & Trust FSB boosted its position in HealthStream by 76.4% during the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 1,025 shares of the technology company’s stock valued at $28,000 after purchasing an additional 444 shares during the period. Hantz Financial Services Inc. boosted its position in HealthStream by 2,035.5% during the 4th quarter. Hantz Financial Services Inc. now owns 1,324 shares of the technology company’s stock valued at $31,000 after purchasing an additional 1,262 shares during the period. Finally, Global Retirement Partners LLC bought a new position in HealthStream during the 2nd quarter worth $31,000. Institutional investors own 69.58% of the company’s stock.

About HealthStream

HealthStream, Inc provides workforce and provider solutions designed for healthcare organizations. Its cloud-based offerings help hospitals, health systems and other healthcare providers manage employee training, education, credentialing, compliance and professional development.

The company’s products and services include learning and talent-management tools, provider credentialing and enrollment solutions, performance assessment, clinical development resources, and patient-experience measurement services.